Neptune Technologies & Bioressources Inc is a Canada-based biotechnology company. The Company is engaged primarily in the development, manufacture and commercialization of marine-derived omega-3 polyunsaturated fatty acids (PUFAs). The Company has three operating segments: Neptune, Acasti Pharma Inc. and NeuroBioPharm Inc. The Company’s Neptune segment produces and commercializes nutraceutical products. The Company’s Acasti Pharma Inc. segment develops and commercializes medical food and pharmaceutical products for cardiovascular diseases. The Company’s NeuroBioPharm Inc. segment develops medical food and pharmaceutical products for neurological diseases. The Company’s lead product, Neptune Krill Oil (NKO), come in capsule form and serve as a dietary supplement to consumers. The Company’s other nutraceutical products include Ecokrill Oil (EKO), Rimfrost Oil, Neptune Krill Aquatein (NKA) and New Formulation Derived from NKO, which include NKO Beat, NKO Flex and NKO Focus.
